Pancreatic Cancer Research

ResearcherNational Research CouncilActive in the last 2 years

Chiara Cencioni

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6284-539X; OpenAlex author ID A5068836888. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2025: 1 paper · 2026: 1 paper

Papers 2

  1. α-ketoglutarate/succinate ratio imbalance impairs thymine DNA glycosylase function and base excision repair process increasing susceptibility to pancreatic can… Co-author DOI 10.1038/s41419-026-08475-w↗
  2. The GLP-1R agonist semaglutide reshapes pancreatic cancer associated fibroblasts reducing collagen proline hydroxylation and favoring T lymphocyte infiltration. Co-author DOI 10.1186/s13046-024-03263-w↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Silvia Malatesta · 2 shared papers, 2025–2026 · strength 0.43
  2. Francesco Spallotta · 2 shared papers, 2025–2026 · strength 0.43
  3. Gian Luca Rampioni Vinciguerra · 1 shared paper, 2026 · strength 0.22
  4. Giulia Piaggio · 1 shared paper, 2026 · strength 0.22
  5. Gianni Colotti · 1 shared paper, 2026 · strength 0.22
  6. Danilo Ranieri · 1 shared paper, 2025 · strength 0.20
  7. Alberto Larghi · 1 shared paper, 2025 · strength 0.20
  8. Vincenzo Corbo · 1 shared paper, 2025 · strength 0.20
  9. Antonio Agostini · 1 shared paper, 2025 · strength 0.20
  10. Geny Piro · 1 shared paper, 2025 · strength 0.20
  11. Giampaolo Tortora · 1 shared paper, 2025 · strength 0.20
  12. Carmine Carbone · 1 shared paper, 2025 · strength 0.20

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.